Correction to: A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis (Neurology and Therapy, (2020), 9, 2, (301-315), 10.1007/s40120-020-00208-1)

Ivan Urits; Daniel Swanson; Michael C. Swett; Anjana Patel; Kevin Berardino; Ariunzaya Amgalan; Amnon A. Berger; Hisham Kassem; Alan D. Kaye; Omar Viswanath

ArticleOPEN ACCESS

Correction to: A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis (Neurology and Therapy, (2020), 9, 2, (301-315), 10.1007/s40120-020-00208-1)

Neurology and Therapy

DOI: 10.1007/s40120-020-00228-x

9Citations

11Readers

Abstract

The middle initial of one of the authors, Alan Kaye, was missed in the original publication. The complete name should read as Alan D. Kaye. The original article has been corrected.

Cite

CITATION STYLE

APA

Urits, I., Swanson, D., Swett, M. C., Patel, A., Berardino, K., Amgalan, A., … Viswanath, O. (2021, June 1). Correction to: A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis (Neurology and Therapy, (2020), 9, 2, (301-315), 10.1007/s40120-020-00208-1). Neurology and Therapy. Adis. https://doi.org/10.1007/s40120-020-00228-x

Correction to: A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis (Neurology and Therapy, (2020), 9, 2, (301-315), 10.1007/s40120-020-00208-1)

Abstract

Cite

Register to see more suggestions